Synteract: Bringing Clinical Trials to Life


Synteract is an innovative CRO supporting biopharma companies in all phases of clinical development to bring new medicines to market. Synteract has conducted 4,000+ studies in 60+ countries, contributing to more than 240 product approvals. We offer notable expertise in dermatology, oncology, pediatrics, neuro degenerative, and rare & orphan indications. 

Oncology​ - Synteract has managed 160+ oncology trials in the past 5 years in complex treatments like pathway-targeted therapies, chemotherapy, immunotherapy, cell-based and gene therapies. We were one of the first CROs to work in immunotherapy over 10 years ago. 

Pediatrics​ - We’ve conducted 310+ pediatric clinical trials globally, in 25+ indications. Our pediatric cross-functional team helps clients navigate complex research to allow medicines to serve the littlest ones.

Dermatology – ​A leading dermatology CRO, we support novel and in-demand dermatology drug development. We’ve conducted 270+ derm trials, in 30+ indications of dermatologic disease and skin care products. 

Neuro Degenerative​ – We’ve managed 130+ neuro degenerative trials in the past 5 years, with extensive experience in drugs addressing Alzheimer’s, Parkinson’s, ALS, MS, migraine, schizophrenia, more.

Rare & Orphan​ - We’ve conducted 130+ trials in rare and orphan diseases in the past 5 years alone. We specialize in unique studies that affect a small portion of the population or are otherwise “forgotten” by other treatments. 

Discover how we can support your clinical trials. Visit or contact us today!